Purchase Order 36C26224P0011
Award Date
10/13/23
Potential Completion Date
10/12/25
Potential Value
$2.3M
Federal Agency
Veterans Integrated Service Network 22
Awardee
Cytopath Biopsy Lab Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
VETERANS ADMIN, CA 90073, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq V2 next generation lab testing services for Veterans Integrated Service Network 1. The contract has a potential value of $717,000.00 and a period of performance through September 30, 2021. This contract is not associated with a set-aside program. Cytopath Biopsy Lab Inc. is a for-profit provider of...
The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed-price delivery order contract to Cytopath Biopsy Lab Inc. (doing business as Cblpath) for its ThyroSeq genetic testing services. The $168,000.00 contract will provide cancer screening and diagnostic services to the VA healthcare system through January 31, 2026. Cytopath Biopsy Lab Inc. has previously provided ThyroSeq testing to support thyroid cancer screening programs at VA medical centers and the Defense Health Agency,...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $428,000.00 to provide THYROSEC TESTING services. The contract supports the VA's cancer screening and diagnosis programs, with Cytopath Biopsy Lab providing specialized thyroid cancer diagnostic testing using its ThyroSeq molecular diagnostic platform. This includes genetic mutation analysis to evaluate malignancy of thyroid nodules detected in...
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), which is part of the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of cytopathology and ThyroSeq genomic testing services, with a ceiling value of $8,000. Cytopath Biopsy Lab Inc. is a for-profit organization that specializes in cancer screening and diagnostic laboratory services, particularly for...
This is a firm fixed-price definitive contract awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for THRYOSEQUENCE TESTING services. The contract has a ceiling value of $248,145.69 and a period of performance through August 14, 2021. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq genetic testing services for the VA's Veterans Integrated Service Network (VISN) 22. The $366,000 contract will support thyroid cancer screening and diagnosis programs at VA healthcare facilities in California, New Mexico, Arizona, and other regional locations. The original solicitation was a...
The Department of Veterans Affairs Veterans Health Administration has awarded a $8,000.00 firm fixed price purchase order to Cytopath Biopsy Lab Inc., doing business as Cblpath, for thyroid molecular testing services. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with experience delivering ThyroSeq genetic testing to support cancer screening and diagnosis programs for the VA and Department of Defense. This contract is not set aside and is...
The Department of Veterans Affairs, Veterans Integrated Service Network 22, awarded a firm fixed-price purchase order contract to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $116,000.00 to provide lab testing services. The contract period of performance runs from January 1, 2019 to December 31, 2019. Cytopath Biopsy Lab Inc. is a for-profit provider of specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and diagnosis...
The U.S. Department of Veterans Affairs (VA) has awarded a firm fixed-price purchase order contract to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide thyroid cancer testing services. The $497,360.00 contract has a performance period through September 30, 2029 and is not designated as a set-aside contract. Cblpath, a for-profit organization that provides specialized anatomic pathology and molecular diagnostic laboratory services, will deliver its ThyroSeq genetic mutation...
This federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the delivery of ThyroSeq molecular diagnostic testing services. The $4,200.00 firm fixed price contract was issued by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12, to support cancer screening and diagnosis programs for veterans. The contract is not set aside and references Cytopath Biopsy Lab Inc.'s prior work providing ThyroSeq genetic testing for...